In the context of health research, both observational studies and clinical trials are crucial for understanding disease processes, patient outcomes, and the safety and efficacy of treatments. However, due to varying regulatory requirements and standards, the archiving requirements for these types of studies are distinct. Here are some of the key differences:
[1] Regulations and Guidelines: Clinical trials as governed by a global set of ethical and scientific standards, such as ICH GCP. These standards are then adopted into law in different regions, say for instance, through the Regulation EU/536/2014, and 21 CFR 312 in the US. These rules are clear about how to manage, store, and archive data and require specific documents to prove the integrity of the trial data. They also set out how long these crucial documents should be kept (e.g., at least 25 years).
On the flip side, observational studies aren’t governed by such unified requirements when it comes to document retention and archiving. They still follow ethical guidelines and good practice principles like the Declaration of Helsinki, ISPE GPP, and STROBE guidelines, but these may not give you exact retention times or archiving mechanisms.
[2] Data Collection and Confidentiality: Clinical trials are data-rich; they collect a large amount of confidential and sensitive patient data. Regular sponsor audits and regulatory inspections mean they need to keep robust records. Observational studies, while they also handle sensitive data, usually don’t interact with patients as much and don’t face as many regulatory inspections. So, they’ve traditionally not had to maintain as meticulous records.
[3] Data Accessibility: Clinical trial data is often more restricted in terms of who can access it and how it can be shared. This is due to both regulatory needs and commercial interests. Observational data, though, is often used for big-picture disease studies, and it’s usually designed to be more shareable – as long as it’s anonymized and ethical procedures are followed.
It’s important to remember that what I’ve explained are general patterns. The exact requirements can change based on region, the type of data you’re dealing with, and even who’s funding your work. If you need specific guidance, don’t hesitate to reach out to an expert or regulatory authority in your area.
Share this story...
Real World Evidence (RWE) 101 – Is ICH GCP Applicable to Non-Interventional Studies?
RWE 101 - Is ICH GCP Applicable to Non-Interventional Studies? No, the International Council for Harmonisation (ICH) Good Clinical Practice (GCP) guidelines are not applicable to non-interventional studies [...]
Real World Evidence (RWE) 101 – Ethical Principles and Safeguards for Medical AI in the Context of Real World Evidence
RWE 101 - Real World Evidence (RWE) 101 - Ethical Principles and Safeguards for Medical AI in the Context of Real World Evidence Medical AI applications hold [...]
Real World Evidence (RWE) 101 – The Declaration of Helsinki
RWE 101 - The Declaration of Helsinki The Declaration of Helsinki is a set of ethical principles that govern the conduct of medical research involving human subjects. [...]
Real World Evidence (RWE) 101 – Ethical Foundation of RWE Research
RWE 101 - Real World Evidence (RWE) 101 - Ethical Foundation of RWE Research Real-world evidence (RWE) research, which is the study of data from real-world settings, is [...]
Real World Evidence (RWE) 101 – The Impact of GDPR on RWE Research
RWE 101 - Real World Evidence (RWE) 101 - The Impact of GDPR on RWE Research The General Data Protection Regulation (GDPR) is a regulation in EU [...]
Real World Evidence (RWE) 101 – De-Identification versus Pseudo-Anonymisation
RWE 101 - Real World Evidence (RWE) 101 - De-Identification versus Pseudo-Anonymisation De-identification and pseudo-anonymization are two commonly used techniques for protecting personal information in real world [...]







